BioNTech Rings the Nasdaq Stock Market Opening Bell - Nasdaq
| 0A3M Stock | 116.10 4.01 3.58% |
Slightly above 55% of BioNTech's private investors are presently thinking to get in. The analysis of overall sentiment of trading BioNTech SE stock suggests that some investors are interested at this time. BioNTech's investing sentiment can be driven by a variety of factors including economic data, BioNTech's earnings reports, geopolitical events, and overall market trends.
BioNTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioNTech daily returns and investor perception about the current price of BioNTech SE as well as its diversification or hedging effects on your existing portfolios.
BioNTech |
BioNTech Rings the Nasdaq Stock Market Opening Bell Nasdaq
Read at news.google.com
 |
BioNTech Fundamental Analysis
We analyze BioNTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
BioNTech is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
BioNTech SE Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
Peers
BioNTech Related Equities
| SSON | Smithson Investment | 1.22 | ||||
| 0IL1 | Federal Realty | 1.14 | ||||
| 0RH1 | Kinnevik Investment | 0.61 | ||||
| PRIM | Primorus Investments | 0.00 | ||||
| FCIT | FC Investment | 0.18 | ||||
| 0UYN | GoldMining | 4.03 |
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.